Thirty out of 49 major developed countries could see their credit ratings plummet to junk status if they don’t make changes soon, says a Standard & Poor’s study. The biggest problem is health care spending on the elderly, parti…
Global pharmaceutical sales are expected to grow by 5% to 7% in 2011, thanks to robust growth in emerging markets, especially China, as well as new innovative treatments, and despite patent expirations and budget pressures in t…
Changes to the U.S. health care system take effect today. But while the measures will clearly benefit many Americans, the new law’s real price tag is still a subject of fierce disagreement.
Continue reading Hea…
Development of technologically advanced — and expensive — lifesaving treatments will continue to increase as the new health care reform law is phased in over the next few years.
Continue reading Technology an…
Health care costs will increase between 10.5% and 11% over the next year, marginally higher than last year’s rise, consulting firm Aon said Wednesday. Aon pins the increase on factors such as rising prescription drug costs and …